Feng Sun Selected Research

Castration

1/2020	Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
7/2015	A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants.
10/2011	Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.
7/2010	Compensatory upregulation of tyrosine kinase Etk/BMX in response to androgen deprivation promotes castration-resistant growth of prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Sun Research Topics

Disease

52	Neoplasms (Cancer) 04/2022 - 09/2004
15	Infections 12/2022 - 10/2008
15	Type 2 Diabetes Mellitus (MODY) 09/2020 - 01/2012
13	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 03/2009
12	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2016
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
7	Carcinogenesis 01/2020 - 12/2009
7	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2009
6	COVID-19 12/2022 - 01/2020
6	Congenital Hypothyroidism (Cretinism) 01/2022 - 10/2019
6	Inflammation (Inflammations) 01/2021 - 02/2006
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 03/2011
6	Hypertension (High Blood Pressure) 01/2020 - 09/2009
6	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 12/2013
5	Tuberculosis (Tuberculoses) 12/2020 - 05/2010
5	Wounds and Injuries (Trauma) 05/2020 - 02/2015
5	Virus Diseases (Viral Diseases) 01/2020 - 12/2014
4	Body Weight (Weight, Body) 01/2022 - 01/2013
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2021 - 01/2019
4	Necrosis 01/2021 - 08/2014
4	Diarrhea 11/2019 - 09/2004
4	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 10/2008
3	Heart Arrest (Cardiac Arrest) 11/2022 - 06/2017
3	Endometriosis 01/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
3	Ventricular Fibrillation 01/2022 - 01/2017
3	Weight Loss (Weight Reduction) 01/2022 - 01/2015
3	Adenomyosis 02/2021 - 01/2021
3	Extensively Drug-Resistant Tuberculosis 01/2019 - 02/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 08/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 06/2015
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2022 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2021
2	Chemical and Drug Induced Liver Injury 01/2022 - 03/2015
2	Overweight 01/2022 - 09/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021 - 06/2021
2	Respiratory Syncytial Virus Infections 10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2009
11	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2012
11	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2011
8	Long Noncoding RNAIBA 01/2022 - 07/2016
8	ThuliumIBA 01/2019 - 12/2013
7	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2018
7	AndrogensIBA 01/2020 - 03/2009
7	Androgen Receptors (Androgen Receptor)IBA 01/2016 - 03/2009
6	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2016
5	Insulin (Novolin)FDA Link 10/2022 - 05/2005
5	CytokinesIBA 01/2022 - 12/2016
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2008
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2012
5	Messenger RNA (mRNA)IBA 10/2020 - 07/2013
5	IncretinsIBA 01/2020 - 03/2018
5	Small Interfering RNA (siRNA)IBA 01/2020 - 07/2010
4	Hormones (Hormone)IBA 10/2022 - 04/2009
4	C-Reactive ProteinIBA 01/2022 - 10/2017
4	EnzymesIBA 04/2021 - 07/2010
4	Biological ProductsIBA 01/2021 - 06/2015
4	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2015
4	Biosimilar PharmaceuticalsIBA 10/2019 - 01/2019
4	3-deazaneplanocinIBA 09/2015 - 12/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2015
3	AlbuminsIBA 01/2022 - 10/2017
3	SteroidsIBA 06/2021 - 10/2012
3	GlucocorticoidsIBA 02/2021 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 07/2010
3	Competitive Endogenous RNAIBA 01/2021 - 12/2017
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2018
3	oxidized low density lipoproteinIBA 12/2020 - 10/2013
3	Peptides (Polypeptides)IBA 12/2020 - 01/2019
3	Histones (Histone)IBA 01/2020 - 12/2009
3	ThiazolidinedionesIBA 12/2019 - 01/2016
3	Therapeutic UsesIBA 11/2019 - 02/2004
3	Antitubercular AgentsIBA 01/2019 - 05/2010
3	Epidermal Growth Factor (EGF)IBA 03/2018 - 10/2011
3	Triglycerides (Triacylglycerol)IBA 01/2018 - 02/2010
3	InterferonsIBA 01/2018 - 11/2011
2	Antiviral Agents (Antivirals)IBA 12/2022 - 02/2021
2	ORALIT (ORS)IBA 05/2022 - 12/2019
2	Carcinoembryonic AntigenIBA 04/2022 - 03/2021
2	AntigensIBA 04/2022 - 03/2020
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2011
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2021
2	VaccinesIBA 12/2021 - 12/2014
2	Dual OxidasesIBA 12/2021 - 01/2021
2	bedaquiline (R207910)IBA 10/2021 - 01/2019

Therapy/Procedure

28	Therapeutics 01/2022 - 03/2010
10	Drug Therapy (Chemotherapy) 01/2022 - 12/2011
8	Lasers (Laser) 01/2019 - 12/2013
6	Gastrectomy 01/2022 - 10/2017
5	Cardiopulmonary Resuscitation (CPR) 11/2022 - 01/2017
4	Artificial Respiration (Mechanical Ventilation) 12/2020 - 01/2017
4	Castration 01/2020 - 07/2010
3	Extracorporeal Membrane Oxygenation 11/2022 - 09/2020
2	Aftercare (After-Treatment) 05/2022 - 02/2021
2	Art Therapy 02/2021 - 01/2021